Intrauterine Devices Market Analysis and Forecast to 2032: By Type (Copper, Hormonal), Age Group (15-24, 25-34, 35-44, Above 44), End-user (Hospitals, Clinics, Community Healthcare Centers, Others), and Region

The global Intrauterine Devices Market was valued at US$ 3.0 billion in 2022 and it is anticipated to grow up to US$ 4.4 billion by 2032, at a CAGR of 3.9% during the forecast period.

An Intrauterine device is a T-shaped plastic or copper birth control medical device inserted into the uterus to prevent pregnancy. It releases copper into the womb, altering the cervical mucus and making it difficult for sperm to reach and survive an egg. It can also prevent a fertilized egg from implanting itself. IUDs are widely preferred over other methods of contraception because they are compact, safe, and cost-effective, and they have no hormonal side effects such as acne, headaches, or breast tenderness. It is currently available in various types that can last for a period of 5 to 10 years.

Global Intrauterine Devices Market Scope and Report Structure
Report Attribute Details
Market Size in 2021$3.0 bn
Market Size in 2031$4.4bn
Growth Rate (2021-31)3.9%
Historic Period2016-2021
Forecast Period2023-2032
Base Year2022
Segments CoveredType, Age Group, End-User, and Region
Key CompaniesAbviee Inc. (US), CooperSurgical Inc. (US), DKT International (US), Eurogine, S.L. (Spain), HLL Lifecare (India), Lupin Pharmaceuticals (India), Mona Lisa NV (Germany), Pregna International Limited (India), Prosan International BV (Netherlands), and Viatris Inc (US) among others.
Regional ScopeNorth America, Europe, Asia Pacific, Central & South America, Middle East & Africa
Analysis CoverageMarket Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments
Market Drivers and Trends

The rise in awareness over the availability of the devices through campaigns is the primary driver of the industry’s growth. One of the key factors influencing global demand for IUDs are initiatives taken by various countries’ health agencies, in collaboration with non-profit organizations (NPOs), to raise awareness about family planning, the benefits of birth control measures, and health-related issues caused by unplanned pregnancies are promoting market growth. Furthermore, because IUDs have a very low risk of ectopic pregnancy, they are gaining popularity among nulliparous women and adolescents who have never given birth and are at a higher risk for negative birth outcomes such as breast and reproductive cancers.

Furthermore, the rise in unplanned and unwanted pregnancies, which has become one of the world’s major concerns. For Instance, according to the World Health Organization (WHO) and the International Federation of Medical Students’ Associations’ 2018 report, approximately 22 million unsafe abortions are performed globally each year, resulting in the deaths of an estimated 47,000 women, Aside from that, the development of advanced product variants with fewer side effects, such as postpartum, slimmer, and reusable IUDs, is expected to offer lucrative growth opportunities to industry investors in the coming years. These factors are expected to drive the growth of the global Intrauterine Devices Market.

Market Restraints and Challenges

The factors that are impeding the market lack of proper knowledge on use of devices, pelvic inflammatory infection, infertility issues, and limited access for conception are limiting the market growth. Additionally, fewer patients experience side effects such as cramps, irregular periods, heavy periods with stronger cramping and others are hindering the global Intrauterine Devices Market growth and further restrict the growth of the market.

Global Intrauterine Devices Market Segmental Overview

The report analyses the global Intrauterine Devices Market based on type, age-group, end-user, and region.

Global Intrauterine Devices Market by Type

Based on type, it is bifurcated into copper, and hormonal. The hormonal segment is expected to be the largest segment in the Intrauterine Devices Market in 2022.One of the primary drivers is the increasing preference among women for long-acting reversible contraceptive methods that offer both high efficacy and convenience. Hormonal IUDs, characterized by their ability to release progestin, not only provide effective birth control but also offer benefits such as reduced menstrual bleeding and alleviation of associated symptoms like dysmenorrhea. Moreover, the ease of insertion and the extended duration of effectiveness, which can range from three to five years depending on the product, make hormonal IUDs an attractive choice for women seeking reliable and hassle-free contraceptive options. This combination of superior contraceptive efficacy, menstrual management, and user convenience has positioned hormonal IUDs as a leading choice in the rapidly growing Intrauterine Devices Market.

Furthermore, because of their numerous health benefits and improved patient outcomes, these hormonal IUDs are recommended by healthcare professionals. Hormonal IUDs are considered extremely safe due to their non-contraceptive benefits and can be used by patients suffering from heavy menstrual bleeding, endometriosis, anaemia, fibroids, and other conditions. Hormonal IUDs prevent pregnancies by thickening the mucus in the cervix and thinned the uterine lining, which partially suppresses ovulation. As a result, the numerous advantages and health benefits provided by hormonal IUDs are expected to drive demand for hormonal IUDs.

Global Intrauterine Devices Market by Age Group 

Based on age group, the market is bifurcated into 15-24, 25-34, 35-44, and above 44. The 25-34 segment dominated the market in 2022, The dominance of the 25-34 age group in the Intrauterine Devices (IUD) market in 2022 can be attributed to several key drivers. This age group often represents individuals who are in their prime childbearing years and may have a heightened awareness of the need for effective contraception methods to plan their families. Moreover, there has been a notable increase in the overall awareness and education surrounding IUDs as a reliable and long-acting contraceptive option, making them a preferred choice for those seeking to delay or control their family planning. Furthermore, concerns about adolescent sexual activity have contributed to this trend, as early sexual engagement can lead to premarital and unplanned pregnancies, a risk that this age group aims to mitigate through the use of IUDs. The desire for greater reproductive autonomy and the ability to balance personal and professional aspirations also drive the adoption of IUDs among those aged 25-34, as they seek to avoid the potential disruptions that can arise from unplanned pregnancies, including early school termination or abortion. These factors collectively make IUDs a favored choice among individuals in the 25-34 age group for their contraceptive needs.

Global Intrauterine Devices Market by End-User

Based on end-user, the Intrauterine Devices Market is segmented into hospitals, clinics, community healthcare centers and others. The hospital segment dominated the market in 2022. This is attributed to the increasing number of patient visits for family planning, which serves as a significant driver for market growth during the forecast period. Hospitals are often the primary healthcare providers for women seeking contraception and family planning services, as they offer a comprehensive range of reproductive health services and have well-established gynecological departments. This makes hospitals a convenient and trusted choice for women seeking IUD insertion, as they can receive expert guidance, counseling, and medical care, thereby contributing to the higher utilization of IUDs in a hospital setting. Moreover, the hospital setting ensures adherence to stringent medical protocols, ensuring that the insertion and management of IUDs are performed with precision, reducing the risk of complications and promoting patient safety and satisfaction. This, coupled with the increasing awareness and acceptance of IUDs as a reliable and long-acting contraceptive method, will strengthen the hospital as well as Intrauterine Devices Market growth during the forecast period.

Geographical Analysis of Global Intrauterine Devices Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The North America is dominating in the Intrauterine Devices Market. First and foremost, the region benefits from a robust healthcare infrastructure, coupled with advanced research and development capabilities, fostering the innovation and commercialization of cutting-edge IUD technologies. Moreover, a high level of awareness and acceptance of contraceptives among the populace, supported by comprehensive sex education and well-established healthcare policies, has significantly propelled the demand for IUDs.

Additionally, the presence of key market players and a favorable regulatory environment, characterized by stringent quality standards and streamlined approval processes, further bolsters the region’s leadership in the global IUD market, facilitating the rapid adoption and distribution of these devices across the continent.  Moreover, high demand for both copper and hormone-based devicesi. For instance, in the United States, around 62 million women use contraception, with approximately 43 million at risk of unintended pregnancy. Additionally, government initiatives promoting birth control awareness and affordability further fuel market growth.

Major Players in the Global Intrauterine Devices Market

The key players studied in the global Intrauterine Devices Market are Abviee Inc. (US), CooperSurgical Inc. (US), DKT International (US), Eurogine, S.L. (Spain), HLL Lifecare (India), Lupin Pharmaceuticals (India), Mona Lisa NV (Germany), Pregna International Limited (India), Prosan International BV (Netherlands), and Viatris Inc (US) among others.

COVID-19 Impact

The COVID-19 pandemic had a significant impact on the market, because the intrauterine devices market is heavily reliant on physician-administered and physician-prescribed intrauterine devices, the number of patient visits for contraception in hospitals has decreased. However, restrictions on physician office visits without an emergency were imposed during the first few months of the ongoing pandemic. Half of the population considering family planning during COVID-19 shifted their interest from intrauterine devices to other contraception methods such as contraception pills, resulting in a worldwide decline in demand for intrauterine device products. The Health Management Information System, which is part of the Health Ministry’s 2020 union, reported that the rate of intrauterine device insertion decreased by 21% during the COVID-19.

According to a research study by Anita Makins, which was published in Gynecology & Obstetrics Journal May 2020, states that there is an huge stock-out of contraceptive methods during the COVID-19 pandemic 2020. Furthermore, the United Nations Population Fund predicted that 46 countries that typically receive supplies from them has experienced stock-outs of one or more modern methods, which includes copper intrauterine devices, implants, oral contraceptive pills, and condoms, over the next six months beginning in May 2020.

Recent Developments
  • In June 2021, Sebela Pharmaceuticals Inc. is conducting a phase III clinical trial with PRA Health Sciences to evaluate LevoCept, a long-acting reversible intrauterine system, for contraceptive efficacy, safety, and tolerability. The trial is scheduled to conclude in June 2027.
  • In February 2020, Agile Therapeutics, Inc. received FDA approval for Twirla transdermal system, which is indicated as a method of contraception for use in women of reproductive potential with a BMI of 30 kg/m2 who require a combined hormonal contraceptive.
  • In September 2019, Kyleena, a Bayer’s intrauterine device, has been approved by the US Food and Drug Administration. This device is extremely effective at preventing pregnancy and has few side effects.
Frequently Asked Questions

Q1. How big is the Intrauterine Devices Market?

Ans. The global Intrauterine Devices Market size was US$ 3.0 billion in 2022 and is anticipated to reach US$ 4.4 billion in 2032, growing at a rate of 3.9% from 2023 to 2032.

Q2. What is the Intrauterine Devices Market growth rate?

Ans. The growth rate of the Intrauterine Devices Market is 3.9% from 2023 to 2032.

Q3. Which region holds a major market share for the Intrauterine Devices Market?

Ans. North America holds a major market share of the Intrauterine Devices Market in 2022.

Q4. Which segment accounted for the largest Intrauterine Devices Market share?

Ans. Based on type, it is bifurcated into copper, and hormonal. The hormonal segment is expected to be the largest segment in the Intrauterine Devices Market in 2022.

Q5. Who are the key players in the Intrauterine Devices Market?

Ans. The global Intrauterine Devices Market report includes players such as Abviee Inc. (US), CooperSurgical Inc. (US), DKT International (US), Eurogine, S.L. (Spain), HLL Lifecare (India), Lupin Pharmaceuticals (India), Mona Lisa NV (Germany), Pregna International Limited (India), Prosan International BV (Netherlands), and Viatris Inc (US) among others.

Q6. What are the factors driving the Intrauterine Devices Market growth?

Ans. The major factors driving the growth of the market are the rise in awareness over the availability of the devices through campaigns and advances in the treatment of cardiac rhythm disorders.

Q7. What are the key growth strategies of Intrauterine Devices Market players?

Ans. The key growth strategies of Intrauterine Devices Market players are product launch, partnerships, and rise in unplanned and unwanted pregnancies.

Q8. Which region will provide more business opportunities for the Intrauterine Devices Market during the forecast period?

Ans. The North America region will provide more business opportunities for the Intrauterine Devices Market during the forecast period.

Table of Contents

Chapter 1. Intrauterine Devices Market Overview
1.1. Objectives of the Study
1.2. Market Definition and Research & Scope
1.3. Research Limitations
1.4. Research Methodologies
1.4.1. Secondary Research
1.4.2. Market Size Estimation Technique
1.4.3. Forecasting
1.4.4. Primary Research and Data Validation

Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market

Chapter 3. Premium Insights on the Market
3.1. Market Attractiveness Analysis, by Region
3.2. Market Attractiveness Analysis, by Age Group
3.3. Market Attractiveness Analysis, by Type
3.4. Market Attractiveness Analysis, by End-User

Chapter 4. Intrauterine Devices Market Outlook
4.1. Intrauterine Devices Market Segmentation
4.2. Market Dynamics
4.2.1. Market Drivers
4.2.1.1. Driver 1
4.2.1.2. Driver 2
4.2.1.3. Driver 3
4.2.2. Market Restraints
4.2.2.1. Restraint 1
4.2.2.2. Restraint 2
4.2.3. Market Opportunities
4.2.3.1. Opportunity 1
4.2.3.2. Opportunity 2
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Buyers
4.3.4. Bargaining Power of Supplier
4.3.5. Competitive Rivalry
4.4. PESTLE Analysis
4.5. Value Chain Analysis
4.5.1. Raw Industry Vertical Suppliers
4.5.2. Manufacturers
4.5.3. Wholesalers and/or Retailers
4.6. Impact of COVID-19 on the Intrauterine Devices Market
4.7. Impact of the Russia and Ukraine War on the Intrauterine Devices Market

Chapter 5. Intrauterine Devices Market by Age Group
5.1. Market Overview
5.2. 15-24
5.2.1. Key Market Trends & Opportunity Analysis
5.2.2. Market Size and Forecast, by Region, 2022-2032 ($Million)
5.3. 25-34
5.3.1. Key Market Trends & Opportunity Analysis
5.3.2. Market Size and Forecast, by Region, 2022-2032 ($Million)
5.4. 35-44
5.4.1. Key Market Trends & Opportunity Analysis
5.4.2. Market Size and Forecast, by Region, 2022-2032 ($Million)
5.5. Above 44
5.5.1. Key Market Trends & Opportunity Analysis
5.5.2. Market Size and Forecast, by Region, 2022-2032 ($Million)

Chapter 6. Intrauterine Devices Market by Type
6.1. Market Overview
6.2. Copper
6.2.1. Key Market Trends & Opportunity Analysis
6.2.2. Market Size and Forecast, by Region, 2022-2032 ($Million)
6.3. Hormonal
6.3.1. Key Market Trends & Opportunity Analysis
6.3.2. Market Size and Forecast, by Region, 2022-2032 ($Million)

Chapter 7. Intrauterine Devices Market by End-User
7.1. Market Overview
7.2. Hospitals
7.2.1. Key Market Trends & Opportunity Analysis
7.2.2. Market Size and Forecast, by Region, 2022-2032 ($Million)
7.3. Clinics
7.3.1. Key Market Trends & Opportunity Analysis
7.3.2. Market Size and Forecast, by Region, 2022-2032 ($Million)
7.4. Community Healthcare Centers
7.4.1. Key Market Trends & Opportunity Analysis
7.4.2. Market Size and Forecast, by Region, 2022-2032 ($Million)
7.5. Others
7.5.1. Key Market Trends & Opportunity Analysis
7.5.2. Market Size and Forecast, by Region, 2022-2032 ($Million)

Chapter 8. Intrauterine Devices Market, by Region
8.1. Overview
8.2. North America
8.2.1. Key Market Trends & Opportunity Analysis
8.2.2. North America Intrauterine Devices Market Size and Forecast by Age Group, 2022-2032, ($Million)
8.2.3. North America Intrauterine Devices Market Size and Forecast by Type, 2022-2032, ($Million)
8.2.4. North America Intrauterine Devices Market Size and Forecast by End-User, 2022-2032, ($Million)
8.2.5. North America Intrauterine Devices Market Size and Forecast by Country, 2022-2032, ($Million)
8.2.6. The U.S.
8.2.6.1. The U.S. Intrauterine Devices Market Size and Forecast by Age Group, 2022-2032, ($Million)
8.2.6.2. The U.S. Intrauterine Devices Market Size and Forecast by Type, 2022-2032, ($Million)
8.2.6.3. The U.S. Intrauterine Devices Market Size and Forecast by End-User, 2022-2032, ($Million)
8.2.7. Canada
8.2.7.1. Canada Intrauterine Devices Market Size and Forecast by Age Group, 2022-2032, ($Million)
8.2.7.2. Canada Intrauterine Devices Market Size and Forecast by Type, 2022-2032, ($Million)
8.2.7.3. Canada Intrauterine Devices Market Size and Forecast by End-User, 2022-2032, ($Million)
8.2.8. Mexico
8.2.8.1. Mexico Intrauterine Devices Market Size and Forecast by Age Group, 2022-2032, ($Million)
8.2.8.2. Mexico Intrauterine Devices Market Size and Forecast by Type, 2022-2032, ($Million)
8.2.8.3. Mexico Intrauterine Devices Market Size and Forecast by End-User, 2022-2032, ($Million)
8.3. Europe
8.3.1. Key Market Trends & Opportunity Analysis
8.3.2. Europe Intrauterine Devices Market Size and Forecast by Age Group, 2022-2032, ($Million)
8.3.3. Europe Intrauterine Devices Market Size and Forecast by Type, 2022-2032, ($Million)
8.3.4. Europe Intrauterine Devices Market Size and Forecast by End-User, 2022-2032, ($Million)
8.3.5. Europe Intrauterine Devices Market Size and Forecast by Country, 2022-2032, ($Million)
8.3.6. Germany
8.3.6.1. Germany Intrauterine Devices Market Size and Forecast by Age Group, 2022-2032, ($Million)
8.3.6.2. Germany Intrauterine Devices Market Size and Forecast by Type, 2022-2032, ($Million)
8.3.6.3. Germany Intrauterine Devices Market Size and Forecast by End-User, 2022-2032, ($Million)
8.3.7. France
8.3.7.1. France Intrauterine Devices Market Size and Forecast by Age Group, 2022-2032, ($Million)
8.3.7.2. France Intrauterine Devices Market Size and Forecast by Type, 2022-2032, ($Million)
8.3.7.3. France Intrauterine Devices Market Size and Forecast by End-User, 2022-2032, ($Million)
8.3.8. U.K.
8.3.8.1. U.K. Intrauterine Devices Market Size and Forecast by Age Group, 2022-2032, ($Million)
8.3.8.2. U.K. Intrauterine Devices Market Size and Forecast by Type, 2022-2032, ($Million)
8.3.8.3. U.K. Intrauterine Devices Market Size and Forecast by End-User, 2022-2032, ($Million)
8.3.9. Spain
8.3.9.1. Spain Intrauterine Devices Market Size and Forecast by Age Group, 2022-2032, ($Million)
8.3.9.2. Spain Intrauterine Devices Market Size and Forecast by Type, 2022-2032, ($Million)
8.3.9.3. Spain Intrauterine Devices Market Size and Forecast by End-User, 2022-2032, ($Million)
8.3.10. Italy
8.3.10.1. Italy Intrauterine Devices Market Size and Forecast by Age Group, 2022-2032, ($Million)
8.3.10.2. Italy Intrauterine Devices Market Size and Forecast by Type, 2022-2032, ($Million)
8.3.10.3. Italy Intrauterine Devices Market Size and Forecast by End-User, 2022-2032, ($Million)
8.3.11. Rest of Europe
8.3.11.1. Rest of Europe Intrauterine Devices Market Size and Forecast by Age Group, 2022-2032, ($Million)
8.3.11.2. Rest of Europe Intrauterine Devices Market Size and Forecast by Type, 2022-2032, ($Million)
8.3.11.3. Rest of Europe Intrauterine Devices Market Size and Forecast by End-User, 2022-2032, ($Million)
8.4. Asia-Pacific
8.4.1. Key Market Trends & Opportunity Analysis
8.4.2. Asia-Pacific Intrauterine Devices Market Size and Forecast by Country, 2022-2032, ($Million)
8.4.3. Asia-Pacific Intrauterine Devices Market Size and Forecast by Type, 2022-2032, ($Million)
8.4.4. Asia-Pacific Intrauterine Devices Market Size and Forecast by Age Group, 2022-2032, ($Million)
8.4.5. Asia-Pacific Intrauterine Devices Market Size and Forecast by End-User, 2022-2032, ($Million)
8.4.6. China
8.4.6.1. China Intrauterine Devices Market Size and Forecast by Age Group, 2022-2032, ($Million)
8.4.6.2. China Intrauterine Devices Market Size and Forecast by Type, 2022-2032, ($Million)
8.4.6.3. China Intrauterine Devices Market Size and Forecast by Age Group Industry Vertical, 2022-2032, ($Million)
8.4.7. India
8.4.7.1. India Intrauterine Devices Market Size and Forecast by Age Group, 2022-2032, ($Million)
8.4.7.2. India Intrauterine Devices Market Size and Forecast by Type, 2022-2032, ($Million)
8.4.7.3. India Intrauterine Devices Market Size and Forecast by End-User, 2022-2032, ($Million)
8.4.8. Japan
8.4.8.1. Japan Intrauterine Devices Market Size and Forecast by Age Group, 2022-2032, ($Million)
8.4.8.2. Japan Intrauterine Devices Market Size and Forecast by Type, 2022-2032, ($Million)
8.4.8.3. Japan Intrauterine Devices Market Size and Forecast by End-User, 2022-2032, ($Million)
8.4.9. South Korea
8.4.9.1. South Korea Intrauterine Devices Market Size and Forecast by Age Group, 2022-2032, ($Million)
8.4.9.2. South Korea Intrauterine Devices Market Size and Forecast by Type, 2022-2032, ($Million)
8.4.9.3. South Korea Intrauterine Devices Market Size and Forecast by End-User, 2022-2032, ($Million)
8.4.10. Rest of APAC
8.4.10.1. Rest of APAC Intrauterine Devices Market Size and Forecast by Age Group, 2022-2032, ($Million)
8.4.10.2. Rest of APAC Intrauterine Devices Market Size and Forecast by Type, 2022-2032, ($Million)
8.4.10.3. Rest of APAC Intrauterine Devices Market Size and Forecast by End-User, 2022-2032, ($Million)
8.5. Rest of the World
8.5.1. Key Market Trends & Opportunity Analysis
8.5.2. Rest of the World Intrauterine Devices Market Size and Forecast by Age Group, 2022-2032, ($Million)
8.5.3. Rest of the World Intrauterine Devices Market Size and Forecast by Type, 2022-2032, ($Million)
8.5.4. Rest of the World Intrauterine Devices Market Size and Forecast by End-User, 2022-2032, ($Million)
8.5.5. Rest of the World Intrauterine Devices Market Size and Forecast by Country, 2022-2032, ($Million)
8.5.6. Latin America
8.5.6.1. Latin America Intrauterine Devices Market Size and Forecast by Age Group, 2022-2032, ($Million)
8.5.6.2. Latin America Intrauterine Devices Market Size and Forecast by Type, 2022-2032, ($Million)
8.5.6.3. Latin America Intrauterine Devices Market Size and Forecast by End-User, 2022-2032, ($Million)
8.5.7. Middle East
8.5.7.1. Middle East Intrauterine Devices Market Size and Forecast by Age Group, 2022-2032, ($Million)
8.5.7.2. Middle East Intrauterine Devices Market Size and Forecast by Type, 2022-2032, ($Million)
8.5.7.3. Middle East Intrauterine Devices Market Size and Forecast by End-User, 2022-2032, ($Million)
8.5.8. Africa
8.5.8.1. Africa Intrauterine Devices Market Size and Forecast by Age Group, 2022-2032, ($Million)
8.5.8.2. Africa Intrauterine Devices Market Size and Forecast by Type, 2022-2032, ($Million)
8.5.8.3. Africa Intrauterine Devices Market Size and Forecast by End-User, 2022-2032, ($Million)

Chapter 9. Competitive Landscape
9.1. Market Overview
9.2. Market Share Analysis/Key Player Positioning
9.3. Vendor Benchmarking
9.4. Developmental Strategy Benchmarking
9.4.1. New Product Development
9.4.2. Product Launches
9.4.3. Business Expansions
9.4.4. Partnerships, Joint Ventures, and Collaborations
9.4.5. Mergers and Acquisitions

Chapter 10. Company Profiles
10.1. Abviee Inc. (US)
10.1.1. Company Snapshot
10.1.2. Financial Performance
10.1.3. Product Offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis
10.2. CooperSurgical Inc. (US)
10.2.1. Company Snapshot
10.2.2. Financial Performance
10.2.3. Product offerings
10.2.4. Key Strategic Initiatives
10.2.5. SWOT Analysis
10.3. DKT International (US)
10.3.1. Company Snapshot
10.3.2. Financial Performance
10.3.3. Product offerings
10.3.4. Key Strategic Initiatives
10.3.5. SWOT Analysis
10.4. Eurogine, S.L. (Spain)
10.4.1. Company Snapshot
10.4.2. Financial Performance
10.4.3. Product offerings
10.4.4. Key Strategic Initiatives
10.4.5. SWOT Analysis
10.5. HLL Lifecare (India)
10.5.1. Company Snapshot
10.5.2. Financial Performance
10.5.3. Product offerings
10.5.4. Key Strategic Initiatives
10.5.5. SWOT Analysis
10.6. Lupin Pharmaceuticals (India)
10.6.1. Company Snapshot
10.6.2. Financial Performance
10.6.3. Product offerings
10.6.4. Key Strategic Initiatives
10.6.5. SWOT Analysis
10.7. Mona Lisa NV (Germany)
10.7.1. Company Snapshot
10.7.2. Financial Performance
10.7.3. Product offerings
10.7.4. Key Strategic Initiatives
10.7.5. SWOT Analysis
10.8. Pregna International Limited (India)
10.8.1. Company Snapshot
10.8.2. Financial Performance
10.8.3. Product offerings
10.8.4. Key Strategic Initiatives
10.8.5. SWOT Analysis
10.9. Prosan International BV (Netherlands)
10.9.1. Company Snapshot
10.9.2. Financial Performance
10.9.3. Product offerings
10.9.4. Key Strategic Initiatives
10.9.5. SWOT Analysis
10.10. Viatris Inc (US)
10.10.1. Company Snapshot
10.10.2. Financial Performance
10.10.3. Product offerings
10.10.4. Key Strategic Initiatives
10.10.5. SWOT Analysis

*The list of company is subject to change during the final compilation of the report

Global Intrauterine Devices Market Segmentation

By Type

  • Copper
  • Hormonal

By Age Group

  • 15-24
  • 25-34
  • 35-44
  • Above 44

By End-User

  • Hospitals
  • Clinics
  • Community Healthcare Centers
  • Others

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World
    • Latin America
    • Middle East
    • Africa

Order this Report

Have questions about the scope of the report ?

Have specific requirements ?

Budget Constraints ?

Related Reports

Electron microscope sample preparation involves the preparation of…
Laboratory automation is the process of automating various…
Intracranial pressure monitoring devices are medical devices used…
Lancets are small, thin, and sharp medical devices…
The Veterinary Vaccines Market size was USD 9.4…
Companion Animal Diagnostics is a field of veterinary…
The global eyewear market was valued at USD…
Catecholamines are a group of hormones produced by…
The global nuclear medicine/radiopharmaceuticals market was valued at…
Sinus dilation devices are medical devices used to…